name

朱妙桂

sex

age

71 岁

hospital number

510269

height

170 cm

weight

55 kg

BSA

1.63 m2

APACHEⅡ

17 分

Infection source

date

2017/03/03 年/月/日

Sequential Organ Failure Assessment

6 分

Fluid resuscitation

age>=60

septic shock

mechanical ventilation

Early fluid resuscitation

age<60

Pregnant woman

advanced malignant tumor

Pulmonary interstitial fibrosis

Serious arrhythmia

Small Tidal Volume Ventilation

Liver failure

Refuse to participate

Heart disease

比阿培南+奥硝唑

vasoactive agent

120 min

min

3600 min

Temperature

36 ℃

Heart Rate

69 次/分

Breath

16 次/分

Systolic pressure (SP)

128 mmHg

Diastolic pressure

61 mmHg

mean arterial pressure

83 mmHg

Pcv-aCO2

7.1 mmHg

DO2

659.9

VO2

157.0

Ca-vO2

36.3

pH value

7.33

PaO2

161 mmHg

PaCO2

32.7 mmHg

BE

-7.6 mmol/L(±2.3mmol/L)

SaO2

99 %

Blood lactic acid concentration, LAC

1.6 mmol/L

Oxygenation index (PaO2/FiO2)

357.8 mmHg

pH value

7.30

PcvO2

39.8 mmHg

PcvCO2

39.8 mmHg

BE

-7.0 mmol/L

ScvO2

75.5 %

Volume of input

0 ml

Volume of output

0 ml

Volume of urine

0 ml

ultrafiltration volume

0 ml

norepinephrine

Norepinephrine Dosage

0.5 μg/Kg/min

dopamine

Dopamine Dosage

μg/Kg/min

Dobutamine

Dobutamine Dosage

μg/Kg/min

CVP

10 mmHg

cardiac output

4.33 L/min

cardiac index

2.66 L/min/m2

stroke volume

61 ml

Stroke Index

37.4 ml/m2

ITBVI

1143 ml/m2

GEDVI

915 ml/m2

EVLWI

10.3 ml/kg

PVPI

1.6

SVRI

2197 DSm2/cm5

CFI

2.6

GEF

15 %

SVV

5 %

PPV

%

dPmax

903

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

the number of B line

条

LUS

分

B+ Zone

区

IVC(inspiratory phase)

mm

IVC(expiratory phase)

mm

respiratory variations of inferior vena cavae diameter

%

mm

mm

mm

mm

Temperature

36.7 ℃

Heart Rate

69 次/分

Breath

12 次/分

Systolic Pressure

139 mmHg

Diastolic Pressure

67 mmHg

Mean Arterial Pressure

90 mmHg

Pcv-aCO2

3.9 mmHg

DO2

872.8

VO2

176.2

Ca-vO2

32.4

PH value

7.35

PaO2

137.2 mmHg

PaCO2

34.7 mmHg

BE

-5.8 mmol/L

SaO2

98.7 %

Blood Lactic Acid Concentration

1.7 mmol/L

Oxygenation index (PaO2/FiO2)

343 mmHg

PH value

7.33

PcvO2

39.9 mmHg

PcvCO2

38.6 mmHg

BE

-6.2 mmol/L

ScvO2

78.9 %

Volume of input

1350 ml

Volume of output

470 ml

Volume of urine

450 ml

Ultrafiltration Volume

0 ml

Norepinephrine Dosage

9.6 mg

Dopamine Dosage

mg

Epinephrine Dosage

mg

Pituitrin Dosage

U

Dobutamine Dosage

mg

Milrinone Dosage

mg

Levosimendan

CVP

10 mmHg

cardiac output

5.44 L/min

cardiac index

3.34 L/min/m2

stroke volume

78.8 ml

Stroke Index

48.4 ml/m2

ITBVI

1097 ml/m2

GEDVI

878 ml/m2

EVLWI

8.0 ml/kg

PVPI

1.3

SVRI

2036 DSm2/cm5

CFI

3.5

GEF

20 %

SVV

4 %

PPV

%

dPmax

1561

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

The number of B line

条

LUS

分

B+ Zone

区

IVC(inspiratory phase)

mm

IVC(expiratory phase)

mm

Respiratory variations of inferior vena cavae diameter

%

mm

mm

mm

mm

Temperature

36.5 ℃

Heart Rate

76 次/分

Breath

17 次/分

Systolic Pressure

142 mmHg

Diastolic Pressure

70 mmHg

Mean Arterial Pressure

101 mmHg

Pcv-aCO2

2.8 mmHg

DO2

914.3

VO2

161.4

Ca-vO2

25.9

PH value

7.39

PaO2

178 mmHg

PaCO2

30.7 mmHg

BE

-9.4 mmol/L

SaO2

99.2 %

Blood Lactic Acid Concentration

1.3 mmol/L

Oxygenation index (PaO2/FiO2)

445 mmHg

PH value

7.38

PcvO2

40.2 mmHg

PcvCO2

33.5 mmHg

BE

-4.9 mmol/L

ScvO2

81.9 %

Volume of input

2050 ml

Volume of output

982 ml

Volume of urine

950 ml

Ultrafiltration Volume

0 ml

Norepinephrine Dosage

19.2 mg

Dopamine Dosage

mg

Epinephrine Dosage

mg

Pituitrin Dosage

U

Dobutamine Dosage

61.2 mg

Milrinone Dosage

mg

Levosimendan

CVP

12 mmHg

cardiac output

6.23 L/min

cardiac index

3.82 L/min/m2

stroke volume

84.2 ml

Stroke Index

51.6 ml/m2

ITBVI

1129 ml/m2

GEDVI

903 ml/m2

EVLWI

7.8 ml/kg

PVPI

1.3

SVRI

1820 DSm2/cm5

CFI

3.8

GEF

21 %

SVV

3 %

PPV

%

dPmax

1447

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

The number of B line

条

LUS

分

B+ Zone

区

IVC(inspiratory phase)

mm

IVC(expiratory phase)

mm

Respiratory variations of inferior vena cavae diameter

%

mm

mm

mm

mm

Temperature

36.5 ℃

Heart Rate

76 次/分

Breath

14 次/分

Systolic Pressure

152 mmHg

Diastolic Pressure

71 mmHg

Mean Arterial Pressure

107 mmHg

Pcv-aCO2

2.7 mmHg

DO2

929.9

VO2

181.9

Ca-vO2

28.9

PH value

7.39

PaO2

177 mmHg

PaCO2

28.9 mmHg

BE

-6.7 mmol/L

SaO2

99.2 %

Blood Lactic Acid Concentration

1.2 mmol/L

Oxygenation index (PaO2/FiO2)

442.5 mmHg

PH value

7.36

PcvO2

38.9 mmHg

PcvCO2

31.6 mmHg

BE

-6.8 mmol/L

ScvO2

80 %

Volume of input

2777 ml

Volume of output

1593 ml

Volume of urine

1550 ml

Ultrafiltration Volume

0 ml

Norepinephrine Dosage

38.4 mg

Dopamine Dosage

mg

Epinephrine Dosage

mg

Pituitrin Dosage

U

Dobutamine Dosage

288 mg

Milrinone Dosage

mg

Levosimendan

CVP

13 mmHg

cardiac output

6.28 L/min

cardiac index

3.85 L/min/m2

stroke volume

82.6 ml

Stroke Index

50.7 ml/m2

ITBVI

1198 ml/m2

GEDVI

959 ml/m2

EVLWI

8.6 ml/kg

PVPI

1.3

SVRI

1951 DSm2/cm5

CFI

3.7

GEF

21 %

SVV

2 %

PPV

%

dPmax

1597

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

The number of B line

条

LUS

分

B+ Zone

区

IVC(inspiratory phase)

mm

IVC(expiratory phase)

mm

Respiratory variations of inferior vena cavae diameter

%

mm

mm

mm

mm

Temperature

37 ℃

Heart Rate

72 次/分

Breath

16 次/分

Systolic Pressure

156 mmHg

Diastolic Pressure

72 mmHg

Mean Arterial Pressure

102 mmHg

Pcv-aCO2

4.6 mmHg

DO2

830.5

VO2

169.6

Ca-vO2

29.0

PH value

7.41

PaO2

135 mmHg

PaCO2

33.8 mmHg

BE

-1.2 mmol/L

SaO2

96.2 %

Blood Lactic Acid Concentration

1.8 mmol/L

Oxygenation index (PaO2/FiO2)

385.7 mmHg

PH value

7.39

PcvO2

35.8 mmHg

PcvCO2

39.4 mmHg

BE

-1.2 mmol/L

ScvO2

76.7 %

Volume of input

5420 ml

Volume of output

4163 ml

Volume of urine

3700 ml

Ultrafiltration Volume

0 ml

Norepinephrine Dosage

38.4 mg

Dopamine Dosage

mg

Epinephrine Dosage

mg

Pituitrin Dosage

U

Dobutamine Dosage

432 mg

Milrinone Dosage

mg

Levosimendan

CVP

9 mmHg

cardiac output

5.84 L/min

cardiac index

3.58 L/min/m2

stroke volume

81.1 ml

Stroke Index

49.8 ml/m2

ITBVI

1116 ml/m2

GEDVI

893 ml/m2

EVLWI

8.5 ml/kg

PVPI

1.4

SVRI

2165 DSm2/cm5

CFI

3.7

GEF

20 %

SVV

6 %

PPV

%

dPmax

971

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

The number of B line

条

LUS

分

B+ Zone

区

IVC(inspiratory phase)

mm

IVC(expiratory phase)

mm

Respiratory variations of inferior vena cavae diameter

%

mm

mm

mm

mm

Temperature

36.7 ℃

Heart Rate

79 次/分

Breath

16 次/分

Systolic Pressure

145 mmHg

Diastolic Pressure

72 mmHg

Mean Arterial Pressure

99 mmHg

Pcv-aCO2

6.1 mmHg

DO2

804.8

VO2

131.9

Ca-vO2

23.2

PH value

7.39

PaO2

92 mmHg

PaCO2

40.9 mmHg

BE

-0.5 mmol/L

SaO2

95.6 %

Blood Lactic Acid Concentration

0.7 mmol/L

Oxygenation index (PaO2/FiO2)

262.9 mmHg

PH value

7.34

PcvO2

39.7 mmHg

PcvCO2

47 mmHg

BE

-0.7 mmol/L

ScvO2

80 %

Volume of input

7729 ml

Volume of output

5623 ml

Volume of urine

5550 ml

Ultrafiltration Volume

0 ml

Norepinephrine Dosage

38.4 mg

Dopamine Dosage

mg

Epinephrine Dosage

mg

Pituitrin Dosage

U

Dobutamine Dosage

432 mg

Milrinone Dosage

mg

Levosimendan

CVP

8 mmHg

cardiac output

5.7 L/min

cardiac index

3.5 L/min/m2

stroke volume

72.2 ml

Stroke Index

44.3 ml/m2

ITBVI

1049 ml/m2

GEDVI

840 ml/m2

EVLWI

8.2 ml/kg

PVPI

1.4

SVRI

2081 DSm2/cm5

CFI

3.8

GEF

20 %

SVV

11 %

PPV

%

dPmax

939

LVEF

%

FS

%

SV

ml

CO

L/min

E peak

A peak

E/A

Ea(ventricular septum)

Ea(lateral wall)

E/Ea(ventricular septum)

E/Ea(lateral wall)

MAPSE

mm

TAPSE

mm

RV size

LVEDV

ml

LVEDD

cm

The number of B line

条

LUS

分

B+ Zone

区

IVC(expiratory phase)

mm

Respiratory variations of inferior vena cavae diameter

%

IVC(inspiratory phase)

mm

mm

mm

mm

mm

NT-proBNP

pg/ml

BNP

444 pg/ml

cTNI

0.36 ng/ml

Creatine kinase isoenzyme, CKMB

8.2 U/L

Creatinine

127 umol/L

Urea nitrogen

11.3 mmol/l

MDRD

ml/min/1.73m2

Date of examination

yyyy-mm-dd

WBC

10.3 X10*9/L

neutrophilic granulocyte percentage

91 %

Hb

114 g/L

CRP

299..4 mg/L

Procalcitonin, PCT

7.17 ng/ml

Date of test

Sequential Organ Failure Assessment

6 分

NT-proBNP

pg/ml

BNP

699 pg/ml

cTNI

0.57 ng/ml

Creatine kinase isoenzyme, CKMB

7.3 U/L

Creatinine

99 umol/L

Urea nitrogen

8.3 mmol/l

MDRD

ml/min/1.73m2

WBC

10.2 X10*9/L

neutrophilic granulocyte percentage

91.5 %

Hb

111 g/L

CRP

253.35 mg/L

Procalcitonin, PCT

5.23 ng/ml

Sequential Organ Failure Assessment

6 分

NT-proBNP

pg/ml

BNP

316 pg/ml

cTNI

0.43 ng/ml

Creatine kinase isoenzyme, CKMB

6.7 U/L

Creatinine

117 umol/L

Urea nitrogen

6.9 mmol/L

MDRD

ml/min/1.73m2

WBC

8.7 X10*9/L

neutrophilic granulocyte percentage

86.6 %

Hb

110 g/L

CRP

230.4 mg/L

Procalcitonin, PCT

4.15 ng/ml

Sequential Organ Failure Assessment

4 分

Transfusion of Red Cells

Transfusion of Red Cells

U

Plasma infusion

Plasma infusion

500 ml

platelet transfusion

platelet transfusion

U

APACHEⅡ

0 分

Complication

prognosis

28-day mortality

survival time(day)

天

death time

yyyy/mm/dd

diagnosis of death

length of stay

天

duration in ICU

6 天

duration of mechanical ventilation

96 小时

ICU expenses

47330 元

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy

小时